TickerFactsScreenerDevelopers

Seres Therapeutics, Inc. (MCRB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $43.92M2017: -$75.52M2018: -$62.85M2019: -$76.52M2020: -$93.61M2021: $6.69M2022: -$228.82M2023: -$117.35M2024: -$148.61M2025: $1.12M$1.12M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.12M+100.8%
2024-$148.61M-26.6%
2023-$117.35M+48.7%
2022-$228.82M-3521.3%
2021$6.69M+107.1%
2020-$93.61M-22.3%
2019-$76.52M-21.7%
2018-$62.85M+16.8%
2017-$75.52M-272.0%
2016$43.92M—